Activation of nuclear factor kappa B in Crohn's disease

Inflammation Research

Volumn 47, Issue 11, 1998, Pages 440-445

  Ellis, R D ^a   Goodlad, J R ^b   Limb, G A ^a   Powell, J J ^a   Thompson, R P H ^a   Punchard, N A ^c  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b RAIGMORE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BEDFORDSHIRE   (United Kingdom)

Author keywords

Crohn's disease; Disease; Immunohistochemistry; Inflammatory bowel; Macrophages; NF B

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCLONAL ANTIBODY; TRANSCRIPTION FACTOR;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENDOTHELIUM; FEMALE; FROZEN SECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LYMPHOCYTE; MACROPHAGE; MALE; MONONUCLEAR CELL; PROTEIN LOCALIZATION; SUBMUCOSA;

ADOLESCENT; ADULT; CROHN DISEASE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; INTESTINES; MALE; MIDDLE AGED; NF-KAPPA B;

EID: 0031723007     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050358     Document Type: Article

References (29)

1. Baeuerle PA, Henkel T. Function and activation of NFκB in the immune system. Annu Rev Immunol 1994;12:141-79.
2. Osborn L, Kunkel S, Nabel GJ. Tumour necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κB. Proc Natl Acad Sci USA 1989;86:2336-40.
3. Brach MA, Gruss HJ, Riedel D, Mertelsmann R, Herrmann F. Activation of NFκB by interleukin 2 in human blood monocytes. Cell Growth Differ 1992;3:421-7.
4. Shimizu H, Mitomo K, Watanabe T, Okamoto S, Yamamoto K. Involvement of a NFκB-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines. Mol Cell Biol 1990;10:561-8.
5. Baeuerle PA. The inducible transcription activator NFκB: Regulation by distinct protein subunits. Biochim Biophys Acta 1991;1072:63-80.
6. Sen R, Baltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein NFκB by a posttranslational mechanism. Cell 1986;47:921-8.
7. Iademarco MF, McQuillan JJ, Rosen GD, Dean DC. Characterisation of the promoter for vascular cell adhesion molecule-1. J Biol Chem 1992;267:16323-9.
8. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NFκB transcription factor and HIV-1. EMBO J 1991;10:2247-58.
9. Auphan N. DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: Inhibition of NFκB activity through induction of IκB synthesis. Science 1995;270: 286-90.
10. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr. Role of transcriptional activation of IκB-α in mediation of immunosuppression by glucocorticoids. Science 1995;270:283-6.
11. Kaltschmidt C, Kaltschmidt B, Henkel T, Stockinger H, Baeuerle PA. Selective recognition of the activated form of transcription factor NFκB by a monoclonal antibody. Biol Chem Hoppe Seyler 1995;376:9-16.
12. Kaltschmidt C, Kaltschmidt B, Newmann H, Wekerle H, Baeuerle PA. Constitutive NFκB activity in neurones. Mol Cell Biol 1994; 14:3981-92.
13. Saverymuttu SH, Camilleri M, Rees H, Lavender JP, Hodgson HJ, Chadwick VS. Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. Acomparison with colonoscopy, histology, and faecal indium 111-granulocyte excretion. Gastroenterology 1986;90: 1121-8.
14. Murch SH, Braegger CP, Walker-Smith JA, MacDonald TT. Location of tumour necrosis factor-α by immunohistochemistry in chronic inflammatory bowel disease. Gut 1993;34:1705-9.
15. Lennox B. Observations on the accuracy of point counting including a description of a new graticule. J Clin Pathol 1975; 28:99-103.
16. Neurath MF, Pettersson S, Mayer zum Bueschenfelde K, Stober W. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NFκB abrogates established experimental colitis in mice. Nature Med 1996;2:998-1004.
17. Marok R, Winyard PG, Coumbe A, Kus ML, Gaffney K, Blades S, et al. Activation of the transcription factor nuclear factor-κB in human inflamed synovial tissue. Arthritis Rheum 1996;39:583-91.
18. Brand K, Page S, Rogler G, Bartsch A, Brandl R, Kneuchl R, et al. Activated transcription factor nuclear factor-κB is present in the atherosclerotic lesion. J Clin Invest 1996;97:1715-22.
19. Cappello M, Keshav S, Prince C, Jewell DP, Gordon S. Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation. Gut 1992;33:1214-9.
20. Conner EM, Brand S, Grisham MB. Inhibition of a chronic granulomatous colitis by a selective proteasome inhibitor: Antagonist of NFκB activation. Gastroenterology 1996;110:A887.
21. Frankenberger M, Pforte A, Sternsdorf T, Passlick B, Baeuerle PA, Ziegler-Heitbrock HWL. Constitutive nuclear NFκB in cells of the monocyte lineage. Biochem J 1994;304:87-94.
22. Souza HS, Carvalho ATP, Madi K, Lapa e Silva JR, Elia CS. Phenotypic analysis of intestinal non-inflamed mucosa in Crohn's disease: Evidence of mononuclear cell depletion in lamina propria. Eur J Gastroenterol Hepatol 1996;8:563-8.
23. Goodman MJ, Skinner JM, Truelove SC. Abnormalities in the apparently normal bowel mucosa in Crohn's disease. Lancet 1976;1:275-8.
24. Schurmann G, Betzler M, Herbay T, Mattfeldt T, Moller P. Morphological changes of the enteric nervous system in Crohn's disease. Br J Surg 1988;75:1260-1.
25. Dvorak AM, Silen W. Differentiation between Crohn's disease and other inflammatory conditions by electron microscopy. Ann Surg 1985;201:53-63.
26. Bishop AE, Polak JM, Bryant MG, Bloom SR, Hamilton S. Abnormalities of vasoactive intestinal polypeptide-containing nerves in Crohn's disease. Gastroenterology 1980;79:853-60.
27. O'Morain C, Bishop AE, McGregor GP, Levi AJ, Bloom SR, Polak JM, et al. Vasoactive intestinal peptide concentrations and immunocytochemical studies in rectal biopsies from patients with inflammatory bowel disease. Gut 1984;25:57-61.
28. Geboes K, Rutgeerts P, Ectors N, Mebis J, Penninckx F, Vantrappen G, et al. Major histocompatibility class II expression on the small intestinal nervous system in Crohn's disease. Gastroenterology 1992;103:439-47.
29. Schuermann GM, Aber-Bishop AE, Facer P, Lee JC, Rampton DS, Dore CJ, et al. Altered expression of cell adhesion molecules in uninvolved gut in inflammatory bowel disease. Clin Exp Immunol 1993;94:341-347.